CIS and Central Eastern Dermal Fillers Market, By Procedure Type (Wrinkle Removal, Lip Augmentation, Face Lift, Fat Injection, Facial Line Correction, Chin Augmentation, Earlobe Rejuvenation, Lip Plum, Skin Smoothening, Acne Scar Treatment, Lipoatrophy Treatment, and Others), End-User (Clinics, Hospitals, and Others), Distribution Channel (Direct Tender and Third-Party Sales) - Industry Trends and Forecast to 2029.
Market Analysis and Insights
CIS and Central Eastern dermal fillers market is driven by the factors such as the rising geriatric population, an increase in the prevalence of minimally invasive procedures, and growing technological advancements in dermal fillers, which enhance its demand and increase investment in research and development, leading to the market growth. Healthcare expenditure has increased across developed and emerging countries, which is expected to create a competitive advantage for manufacturers to develop new and innovative dermal fillers.
Dermal fillers are substances designed to be injected into the skin to add fullness and volume. The substances used in dermal fillers include calcium hydroxylapatite (a mineral-like compound found in bones), Hyaluronic acid, Polyalkylimide, Polylactic acid, and Polymethyl-methacrylate microspheres (PMMA). Dermal fillers can be classified by several criteria, including the deep dermis, depth of implantation (superficial midterms and upper and subcutaneous levels); longevity of correction (temporary and permanent); allergenicity, the composition of the agent (allografts, semi/fully synthetic, xenografts, or autologous). The increasing use of minimally invasive procedures has been shifted compared to traditional methods for aesthetic and cosmetic surgery techniques, including laser and other energy-based devices. For surgical or non-surgical procedures, specially-designed instruments have been developed for minimally used procedures. These anti-aging devices help reduce the visual effects of skin aging by revitalizing and tightening the skin, which gives a younger look. Minimally-invasive energy-based treatments for skin tightening, wrinkle reduction, face contouring, and skin rejuvenation are in high demand worldwide. However, the high cost of the procedure and side effects associated with the dermal fillers are expected to hamper the CIS and Central Eastern dermal fillers market growth.
CIS and Central Eastern dermal fillers market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. Contact us for an analyst brief to understand the analysis and the market scenario. Our team will help you create a revenue impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for safe distribution of machine and drugs products are the major drivers propelling the market demand in the forecast period.
CIS and Central Eastern dermal fillers market is supportive and aims to treat impairment associated with individual aesthetic appearances. Data Bridge Market Research analyses that the central-eastern dermal fillers market will grow at a CAGR of 17.6% during the forecast period of 2022 to 2029.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Pricing in USD
|
|
Segments Covered
|
By Procedure Type (Wrinkle Removal, Lip Augmentation, Face Lift, Fat Injection, Facial Line Correction, Chin Augmentation, Earlobe Rejuvenation, Lip Plum, Skin Smoothening, Acne Scar Treatment, Lipoatrophy Treatment, and Others), End-User (Clinics, Hospitals, and Others), Distribution Channel (Direct Tender and Third-Party Sales)
|
|
Countries Covered
|
Germany, United Kingdom, France, Netherlands, Switzerland, Poland, Belgium, Ireland, Austria, Romania, Czech Republic, Hungary, Slovakia, Luxembourg, Liechtenstein, and Rest of Central Europe, Russia, Kazakhstan, Belarus, Croatia, Azerbaijan, Moldova, Armenia, Kyrgyzstan, Ukraine, Serbia and Rest of CIS Countries
|
|
Market Players Covered
|
Croma-Pharma GmbH, Sinclair Pharma, Teoxane, BIOXIS Pharmaceuticals, Galderma Laboratories, L.P., Merz Pharma, Allergan, Prollenium Medical Technologies, Suneva Medical Technology, Revance, FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, Bloomage Biotechnology Corporation Limited, Amalian, Pluryal, VITAL ESTHETIQUE, BioScience GmbH, Zimmer Aesthetic, My Med Kft, Bohus BioTech AB, Cytophil Inc, Revitajal, among others
|
Market Definition:
Dermal fillers are substances designed to be injected into the skin to add fullness and volume. The substances used in dermal fillers include Calcium hydroxylapatite (a mineral-like compound found in bones), Hyaluronic acid, Polyalkylimide, Polylactic acid, and Polymethyl-methacrylate microspheres (PMMA). Dermal fillers can be classified based on several criteria, including the deep dermis, depth of implantation (superficial midterms and upper and subcutaneous levels); longevity of correction (temporary and permanent); allergenicity, the composition of the agent (allografts, semi/fully synthetic, xenografts, or autologous); and stimulatory behavior (physiologic processes of endogenous tissue proliferation) versus replacement fillers (space-replacing effect).
Temporary dermal fillers such as HA and collagen are biodegradable and last from 4 to 9 months. The prospective side effects and dissatisfaction are also short-lived. Therefore, temporary fillers are always used as the first line of therapy to save long-lasting fillers for future patient visits.
Permanent fillers are essentially used to alter deep lines and furrows of the skin, which are beyond normal facial wrinkles. They are an excellent option for facial rejuvenation, especially in HIV lipodystrophy. Polymethyl methacrylate (PMMA) is mostly used for safe, effective, and long-lasting effects. . Dermal fillers are becoming very popular for facial rejuvenation methods. Being minimally invasive dermal filler shows instantaneous results in cosmetic volume replacement therapies.
CIS and Central Eastern Dermal Fillers Market Dynamics
Drivers
- Increasing geriatric population
The aging population is pivotal in raising the demand for anti-aging energy-based aesthetic devices. Old age is associated with loss of fibrous tissue and reduced vascular and glandular networks in the skin layers, which lead to wrinkles, dryness, pigmentary alteration, and skin sagging. The application of knowledge aesthetic that delays the physical and mental deterioration associated with senescence to the absolute end of life has been reported attracted toward aesthetic devices among the geriatric population.
The rising facial aging in the skin or within underlying fat and connective tissue, dermal elastosis of the skin, lipodystrophy of the neck, and laxity of the facial ligaments all contribute to the stigmata of the aging face care and concern to appearances that have forward way towards the use of minimally invasive procedures. The increasing need for non-invasive energy-based treatments for skin tightening, wrinkle reduction, face contouring, and skin rejuvenation are responsible for increased use among the geriatric population. Anti-aging devices help reduce the visual effects of skin aging by revitalizing and tightening the skin, which gives a younger look, which is why these are increasingly used by the elderly. Therefore, the increasing geriatric population is expected to drive the central-eastern dermal fillers market growth.
- Technological advancements in dermal fillers
The contribution of technological advancements in healthcare and clinical services is being taken out of the confines and made more accessible. Advanced innovative technologies have improved aesthetic treatment for skin and other body parts wherever necessary. Dermal fillers are in the form of gel-like substances, which are injected beneath the skin to restore the lost volume and soften creases and smooth lines. It is also used to enhance facial contours. This popular facial transformation treatment restores the wrinkles and appearance of facial lines. Dermal fillers are an effective treatment way to look younger without downtime or surgery. Dermal fillers drug is injected into the skin, which helps in filling the facial wrinkles. There are different types of dermal filler drugs available. The most common types are Calcium Hydroxylapatite, Hyaluronic acid, Polyalkylimide, Polylactic acid, and others. Advancements in the dermal fillers brands will help boost the market's demand.
Opportunity
- Increasing awareness towards cosmetic procedures
Digital platforms promote information dissemination to target users. These platforms have a vital function to play in facilitating cosmetic procedures. Historically, surgeons used their private web accounts for awareness. Still, modern surgeons are gradually utilizing Instagram, LinkedIn, Snapchat, Twitter, and other social networking sites to increase awareness toward the detection and treatment of aesthetic appeal and symmetry of the body part designed to combat signs of aging and rejuvenate refreshed skin.
Social media enhances contact, promotion, and awareness for colleagues and the general public. Moreover, researchers noticed that enhanced social network participation coincided with increased concern for plastic surgery and the usage of certain apps. This will lead to a rise in sales, product portfolio, and product line expansion. Thus, the increased consciousness will enable the consumers to opt for the correct treatment of acne and wrinkles and select the right product as per the correct cause. This will lead to a rise in sales, a rise in the product portfolio, and an expansion of the product line. Thus, increasing awareness of the detection and treatment is expected to be an opportunity for the central-eastern dermal fillers market growth.
Restraints/Challenges
- High cost of procedures
The cost of the product plays a major factor in the market. The cost associated with treatment for a longer duration is quite tricky for an average-income person to afford. The utilization of critical care and intensive care unit services is increasing worldwide, and its expensive cost is a major concern in the current healthcare system. The cost of dermal filler depends on the type of filler and the amount used in the treatment. Also, the treatment cost is based on the qualifications and expertise of the person performing the dermal fillers treatment. The cosmetic treatment of dermal filler is a safe outpatient procedure, and it is a very popular treatment for restoring lost volume and treating some signs of aging. Still, the high cost of the procedures is expected to hamper the market's demand.
The cost varies significantly as per their quality, durability, and brand from place to place. The key factors determining the cost of aesthetic procedures include the medical institution or clinic finalized for the procedure, technology used, affected area, duration of the stay of the patient, and complexity of the surgery, among more. The high procedure cost is due to the various checkpoints and the use of high-tech modalities to perform such procedures. As the cost of technologically advanced aesthetic surgery devices is high, the procedure cost proportionally gets escalated, due to which the high cost of the procedure is expected to hamper the central-eastern dermal fillers market growth.
Recent Development
- In April 2022, Sinclair Pharma announced the company had received a European CE mark for Perfectha Lidocaine in treating wrinkle correction, facial contouring, and volume restoration. This CE certificate results in the launch of Perfectha Lidocaine in the UK and all major European markets
- In September 2020, Allergan announced that the company had received FDA approval for Juvederm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula for cheek augmentation to correct age-related volume deficit in the mid-face in adults over 21. This helps blend different molecular weights of hyaluronic acid, contributing to the gel's duration, and is proven to last in the mid-face area for up to 24 months with optimal treatment
- In October 2017, Galderma Laboratories, L.P.announced that the company had received the first FDA-approved dermal filler (HA) for lip-rising in patients 21 years of age and older and is now the first HA dermal filler to be approved for cannula lip injection. This results in expanding the product portfolio of the company, which will ultimately add to the revenue of the company
CIS and Central Eastern Dermal Fillers Market Segmentation
CIS and Central Eastern dermal fillers market is categorized into three notable segments: procedure type, end-user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Procedure Type
- Lip Augmentation
- Face Lift
- Fat Injection
- Face Line correction
- Chin Augmentation
- Earlobe Rejuvenation
- Lip Plum
- Skin Smoothening
- Scar Treatment
- Lipoatrophy Treatment
On the basis of procedure type, the CIS dermal fillers market is segmented into wrinkle removal, lip augmentation, facelift, fat injection, face line correction, chin augmentation, earlobe rejuvenation, lip plum, skin smoothening, acne scar treatment, and lipoatrophy treatment.
End-User
- Clinics
- Hospitals
- Others
On the basis of end-user, the CIS dermal fillers market is segmented into clinics, hospitals, and others
Distribution Channel
- Direct Tender
- Third-Party Sales
On the basis of distribution channels, the central-eastern dermal fillers market is segmented into direct tender and third-party sales.
CIS and Central Eastern Dermal Fillers Market Regional Analysis/Insights
The central-eastern dermal fillers market is analysed, and market size insights and trends are provided by procedure type, end-user and distribution channel as referenced above.
The countries covered in the central-eastern dermal fillers market report are Germany, United Kingdom, France, Netherlands, Switzerland, Poland, Belgium, Ireland, Austria, Romania, Czech Republic, Hungary, Slovakia, Luxembourg, Liechtenstein, and Rest of Central Europe, Russia, Kazakhstan, Belarus, Croatia, Azerbaijan, Moldova, Armenia, Kyrgyzstan, Ukraine, Serbia and Rest of CIS Countries.
Germany is expected to dominate due to an increase in technological advancement in the developing areas.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing a forecast analysis of the country data.
Competitive Landscape and CIS and Central Eastern Dermal Fillers Market Share Analysis
CIS and Central Eastern dermal fillers market competitive landscape provides details by the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points are only related to the companies' focus on the dermal fillers market.
The majors players operating in the market are Croma-Pharma GmbH, Sinclair Pharma, Teoxane, BIOXIS Pharmaceuticals, Galderma Laboratories, L.P., Merz Pharma, Allergan, Prollenium Medical Technologies, Suneva Medical Technology, Revance, FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, Bloomage Biotechnology Corporation Limited, Amalian, Pluryal, VITAL ESTHETIQUE, BioScience GmbH, Zimmer Aesthetic, My Med Kft, Bohus BioTech AB, Cytophil Inc, Revitajal, among others
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning grids, Market Time Line Analysis, Market Overview and Guide, Company Positioning grids, Company Market Share Analysis, Standards of Measurement, Europe vs Regional, and Vendor Share Analysis. Please request an analyst call in case of further inquiry.
SKU-